Apellis Pharmaceuticals, Inc. (APLS) vs Blueprint Medicines Corporation (BPMC)
Detailed comparison between Apellis Pharmaceuticals, Inc., Blueprint Medicines Corporation.Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)Blueprint Medicines Corporation (BPMC)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
Blueprint Medicines Corporation
BPMC
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | Blueprint Medicines Corporation (BPMC) |
|---|---|---|
| Current Price | $18.16 | $84.69 |
| Change | -0.81 (-4.27%) | 2.58 (3.14%) |
| Market Cap | $2.28B | $5.41B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -21.62 | -90.10 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $50.98 | $121.90 |
| 52-Week Low | $17.48 | $73.04 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.60 | $-1.07 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | -24.77% | -39.73% | -61.88% | -47.91% | 29.44% | 29.44% |
| BPMC | -4.54% | -24.36% | -6.53% | 20.80% | 348.81% | 348.81% |